INTC
Intel Corporation
INTC has a slight edge over ZS overall, supported by stronger modeled upside.
ZS
Zscaler, Inc.
ZS has lower modeled downside risk, despite its lower overall score.
INTC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Healthy | |
| Healthy |
INTC's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.
ZS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Strong | |
| Unavailable |
ZS's revenue and cash flow are currently healthy, but its profitability is under pressure. There isn't enough data to rate its balance sheet.
INTC PE Valuation
INTC has no meaningful PE right now: it lost money over the past year.
ZS PE Valuation
ZS has no meaningful PE right now: it lost money over the past year.
INTC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Broad | |
| Low |
Analysts expect earnings and revenue growth for INTC, with profitability improving. However, they disagree widely on these estimates.
ZS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Improving | |
| Broad | |
| High |
Analysts expect earnings and revenue growth for ZS, with profitability improving.
INTC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.41 | — |
| Q3 2026 | -$2.39 | -24000% |
| Q2 2026 | -$2.09 | +$2.68 |
| Q1 2026 | -$0.60 | +$3.88 |
| Q4 2025 | -$0.06 | +$4.32 |
| Q3 2025 | $0.01 | +$3.72 |
| Q2 2025 | -$4.77 | -2088% |
| Q1 2025 | -$4.48 | -562% |
| Q4 2024 | -$4.38 | -1195% |
INTC has swung to a loss: it lost $2.39 per share over the past year, after a profit the year before.
ZS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.04 | — |
| Q3 2026 | -$0.39 | -$0.12 |
| Q2 2026 | -$0.48 | -$0.23 |
| Q1 2026 | -$0.42 | -$0.32 |
| Q4 2025 | -$0.26 | -$0.02 |
| Q3 2025 | -$0.27 | +$0.12 |
| Q2 2025 | -$0.25 | +$0.25 |
| Q1 2025 | -$0.10 | +$0.84 |
| Q4 2024 | -$0.24 | +$0.91 |
ZS is still losing money, but far less than before: $0.39 per share over the past year, against $2.77 at its worst in mid-2022.
INTC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16.5B | +21% |
| Q2 2026 | $16.1B | +25% |
| Q1 2026 | $13.6B | +7.2% |
| Q4 2025 | $13.7B | -4.1% |
| Q3 2025 | $13.7B | +2.8% |
| Q2 2025 | $12.9B | +0.2% |
| Q1 2025 | $12.7B | -0.4% |
| Q4 2024 | $14.3B | -7.4% |
INTC's revenue is recovering but still below its 2021 peak: $16.5B last quarter, up 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +10 points |
| Q2 2026 | 11% | +36 points |
| Q1 2026 | -23% | -21 points |
| Q4 2025 | 4.2% | +1.4 points |
| Q3 2025 | 5% | +73 points |
| Q2 2025 | -25% | -9.4 points |
| Q1 2025 | -2.4% | +6 points |
| Q4 2024 | 2.9% | -14 points |
INTC has the edge over ZS on profitability, with a higher operating margin.
ZS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $898.2M | +25% |
| Q2 2026 | $850.5M | +25% |
| Q1 2026 | $815.8M | +26% |
| Q4 2025 | $788.1M | +26% |
| Q3 2025 | $719.2M | +21% |
| Q2 2025 | $678M | +23% |
| Q1 2025 | $647.9M | +23% |
| Q4 2024 | $628M | +26% |
ZS has the edge over INTC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -1.7% | +2.8 points |
| Q2 2026 | -3.5% | +0.3 points |
| Q1 2026 | -6.3% | -0.1 points |
| Q4 2025 | -4.6% | +0.3 points |
| Q3 2025 | -4.5% | +0.1 points |
| Q2 2025 | -3.8% | -3.2 points |
| Q1 2025 | -6.2% | +2.5 points |
| Q4 2024 | -4.9% | +4.4 points |
ZS's operating margin was −1.7% last quarter, up 2.8 points from the same quarter a year ago, near the top of its range since 2019.
INTC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +774% |
| Q2 2026 | $4.5B | +$6B |
| Q1 2026 | -$2.5B | +$1.8B |
| Q4 2025 | $800M | +$3.5B |
| Q3 2025 | $121M | +$2.5B |
| Q2 2025 | -$1.5B | +$1.9B |
| Q1 2025 | -$4.4B | +$2.8B |
| Q4 2024 | -$2.7B | -$597M |
INTC's free cash flow has turned positive after four years mostly in the red: $3.8B over the past year.
ZS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $79.4M | -58% |
| Q2 2026 | $155.6M | +12% |
| Q1 2026 | $186.3M | +13% |
| Q4 2025 | $431M | +37% |
| Q3 2025 | $190.6M | +24% |
| Q2 2025 | $138.9M | +0.8% |
| Q1 2025 | $164.4M | +48% |
| Q4 2024 | $314.3M | +35% |
ZS's free cash flow has been positive every quarter for seven years: $852M over the past year, up 5.5% from the year before.
INTC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4% | +203M shares |
| 1 year | +17% | +776M shares |
| 3 years | +25% | +1.1B shares |
| 5 years | +30% | +1.2B shares |
| Available history | +19% | +834M shares |
INTC has 5.3B diluted shares, up 17% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | $114M |
| Q1 2021 | $2.3B |
ZS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -522K shares |
| 1 year | +3.8% | +5.8M shares |
| 3 years | +11% | +15.3M shares |
| 5 years | +18% | +24.6M shares |
| Available history | +26% | +32.7M shares |
ZS has the edge over INTC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
INTC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.0x | Healthy |
| Q2 2026 | 3.1x | Elevated |
| Q1 2026 | 3.9x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 4.0x | Elevated |
| Q1 2025 | 69.6x | High |
| Q3 2024 | 23.8x | High |
| Q2 2024 | 4.3x | High |
INTC's net debt is about 2.0 years of its operating earnings (EBITDA), down from 4.0 years a year ago.
ZS Net Leverage
ZS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
INTC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.1 | Neutral |
| Stochastic | 7.7 | Oversold |
INTC's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
ZS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.1 | Neutral |
| Stochastic | 49.0 | Neutral |
ZS's weekly RSI is 51 (neutral) and its Stochastic is 49 (neutral).
INTC PE vs Technology Sector
| Metric | INTC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
INTC has no meaningful PE right now: it lost money over the past year.
ZS PE vs Technology Sector
ZS has no meaningful PE right now: it lost money over the past year.
INTC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $88.4 | 31% below |
| 20 week MA | $95.3 | 36% below |
| 50 week MA | $79.3 | 23% below |
| 100 week MA | $52.1 | 18% above |
| 200 week MA | $42.5 | 44% above |
INTC has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 44% above its 200-week average.
ZS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $214.3 | 9.8% below |
| 20 week MA | $184.7 | 4.6% above |
| 50 week MA | $175.4 | 10% above |
| 100 week MA | $214.1 | 9.7% below |
| 200 week MA | $192.3 | 0.5% above |
ZS has the edge over INTC on trend strength, trading above more of its moving averages.
INTC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $60.1 | $47.1 | -22% |
| 2021 | $47.1 | $51.3 | +9% |
| 2022 | $51.3 | $26.1 | -49% |
| 2023 | $26.1 | $50.3 | +93% |
| 2024 | $50.3 | $20.3 | -60% |
| 2025 | $20.3 | $36.2 | +78% |
| 2026 YTD | $36.2 | $61.2 | +69% |
INTC has the edge over ZS on returns for 2026, with the stronger performance.
ZS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $47.6 | $205.3 | +331% |
| 2021 | $205.3 | $323.0 | +57% |
| 2022 | $323.0 | $108.8 | -66% |
| 2023 | $108.8 | $221.6 | +104% |
| 2024 | $221.6 | $184.6 | -17% |
| 2025 | $184.6 | $230.5 | +25% |
| 2026 YTD | $230.5 | $193.2 | -16% |
ZS's yearly returns have swung widely, from +331% in 2020 to −66% in 2022. It's down 16% so far in 2026.